The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers
Open accessAbstract
Silica nanoparticles (SNP) have gained tremendous attention in the recent decades. They have been used in many different biomedical fields including diagnosis, biosensing and drug delivery. Medical uses of SNP for anti-cancer, anti-microbial and theranostic applications are especially prominent due to their exceptional performance to deliver many different small molecules and recently biologics (mRNA, siRNA, antigens, antibodies, proteins, and peptides) at targeted sites. The physical and chemical properties of SNP such as large specific surface area, tuneable particle size and porosity, excellent biodegradability and biocompatibility make them an ideal drug delivery and diagnostic platform. Based on the available data and the pre-clinical performance of SNP, recent interest has driven these innovative materials towards clinical application with many of the formulations already in Phase I and Phase II trials. Herein, the progress of SNP in biomedical field is reviewed, and their safety aspects are analysed. Importantly, we critically evaluate the key structural characteristics of SNP to overcome different biological barriers including the blood-brain barrier (BBB), skin, tumour barrier and mucosal barrier. Future directions, potential pathways, and target areas towards rapid clinical translation of SNP are also recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–221 of 221
Wang, Y., Cheng, S., Hu, W., Lin, X. L., Cao, C., Zou, S., Tong, Z., Jiang, G., & Kong, X. (2021) · Frontiers of Materials Science · doi:10.1007/s11706-021-0532-1 · Cited by 33
Raza, A., Alavi, S. E., Sime, F. B., Han, F. Y., Roberts, J. A., Popat, A., Falconer, J. R., & Kumeria, T. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.042 · Cited by 31
Self-citationHosseinpour, S., Cao, Y., Liu, J., Xu, C., & Walsh, L. J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02756a · Cited by 30
Self-citationPunz, B., Johnson, L., Geppert, M., Dang, H.-H., Horejs‐Hoeck, J., Duschl, A., & Himly, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051103 · Cited by 28
DNA Vaccine Mediated by Rambutan‐Like Mesoporous Silica Nanoparticles
Song, H., Yang, Y., Tang, J., Gu, Z., Wang, Y., Zhang, M., & Yu, C. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900154 · Cited by 27
Self-citationJambhrunkar, M., Yang, Y., Yu, M., Zhang, M., Abbaraju, P. L., Ghosh, T., Kalantari, M., Wang, Y., McMillan, N. A. J., & Yu, C. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2020.100069 · Cited by 26
Self-citationOral intake of mesoporous silica is safe and well tolerated in male humans
Hagman, E., Elimam, A., Kupferschmidt, N., Ekbom, K., Rössner, S., Iqbal, M. N., Johnston, E. V., Lindgren, M., Bengtsson, T., & Danielsson, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240030 · Cited by 25
Silicosis in Current Scenario: A Review of Literature
Sen, S., Mitra, R., Mukherjee, S., Das, P. K., & Moitra, S. (2015) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11666151026221845 · Cited by 23
Enhanced topical econazole antifungal efficacy by amine-functionalized silica nanoparticles
Montazeri, M., Razzaghi‐Abyaneh, M., Nasrollahi, S. A., Maibach, H. I., & Nafisi, S. (2019) · Bulletin of Materials Science · doi:10.1007/s12034-019-1974-2 · Cited by 23
Lin, C.-Y., Yang, C., & Lindén, M. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.09.164 · Cited by 23
Meka, A. K., Gopalakrishna, A., Iriarte‐Mesa, C., Rewatkar, P. V., Qu, Z., Wu, X., Cao, Y., Prasadam, I., Janjua, T. I., Kleitz, F., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00017 · Cited by 23
Self-citationRambutan-like silica nanoparticles at tailored particle sizes for plasmid DNA delivery
Hines, E. M., Cheng, D., Wu, W., Yu, M., Xu, C., Song, H., & Yu, C. (2021) · Journal of Materials Science · doi:10.1007/s10853-020-05660-w · Cited by 20
Self-citationLiu, Q., Sun, Y., Yin, X., Li, J., Xie, J., Xie, M., Wang, K., Wu, S., Li, Y., Hussain, M., et al. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00299 · Cited by 19
Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics?
Valetti, S., Thomsen, H., Wankar, J., Falkman, P., Manet, I. G. J., Feiler, A. A., Ericson, M. B., & Engblom, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120609 · Cited by 19
Plaza-Oliver, M., Santander-Ortega, M. J., Castro‐Vázquez, L., Robledo, V. R., González-Fuentes, J., Marcos, P., Lozano, M. V., & Jiménez, M. D. M. A. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110740 · Cited by 18
Nanodispersed UV blockers in skin-friendly silica vesicles with superior UV-attenuating efficiency
Zhang, J., Raphael, A. P., Yang, Y., Popat, A., Prow, T. W., & Yu, C. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01332h · Cited by 17
Self-citationJoubert, R., Steyn, D., Heystek, H. J., Steenekamp, J. H., du Preez, J. L., & Hamman, J. H. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1211639 · Cited by 17
Feng, Y., Cao, Y., Qu, Z., Janjua, T. I., & Popat, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092239 · Cited by 15
Self-citationYang, Y., Zhang, M., Yang, Y., Cheng, D., & Yu, C. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102704 · Cited by 14
Self-citationLi, X., Pang, K., Ng, T. W., Leung, P. C., Zhang, C., Leung, K. C., & Jin, L. (2016) · Nanomaterials · doi:10.3390/nano6110192 · Cited by 9
Irreversible Adsorption of Serum Proteins onto Nanoparticles
von Baeckmann, C., Kählig, H., Lindén, M., & Kleitz, F. (2020) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202000273 · Cited by 6
Self-citation
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Metadata
- Authors
- Janjua, T. I., Cao, Y., Kleitz, F., Linden, M., Yu, C., & Popat, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 203
- Pages
- 115115
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4387643426
- Cited by
- 259
- References
- 221
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.